Prothrombin time (PT) and INR: what the test measures, normal levels, and what a high PT or INR means

Blood clots through a chain of proteins called clotting factors, most of them made by the liver. The prothrombin time test takes the liquid part of your blood, adds tissue factor (the trigger your body releases when a vessel is injured) and calcium, and times how long a clot takes to form. That timing depends on five factors in particular: factor VII, factor X, factor V, prothrombin (factor II) and fibrinogen. If any of them is low or not working, the clot forms late and the PT is prolonged.

Four of those factors need vitamin K to be made in a working form, which is why PT is the test that tracks warfarin (a vitamin K blocker), vitamin K deficiency and the failing production of a damaged liver. It says nothing about platelets and little about the other half of the clotting cascade, which is tested separately by the partial thromboplastin time (PTT).

Because the reagent used to trigger the clot varies between manufacturers, the same blood sample can give a PT of 12 seconds in one lab and 14 in another. The International Normalized Ratio, or INR, fixes that: it divides your PT by the lab's normal PT and adjusts for the reagent's sensitivity, producing a ratio that means the same thing everywhere. Most reports show both numbers; clinicians managing warfarin read the INR.

The largest group is people taking warfarin. Warfarin has a narrow window between too little effect (clots) and too much (bleeding), and dose requirements shift with diet, other medications and illness, so the INR is checked frequently when a dose is started or changed and then, once stable, roughly every four weeks, with intervals of up to twelve weeks acceptable for people whose readings have stayed steady. Many warfarin patients test at home with a fingerstick meter and report the value to their anticoagulation clinic.

PT/INR is also part of the work-up for bleeding that has no obvious cause: bruising easily or in unusual places, nosebleeds that are hard to stop, prolonged bleeding after dental work or a cut, blood in the urine or stool, or heavy periods. It is a standard measure of liver function, because a rising INR shows the liver is no longer making enough clotting factor, and it feeds the scores that stage liver disease. Suspected vitamin K deficiency (poor intake, prolonged antibiotics, malabsorption, newborns), disseminated intravascular coagulation in acutely ill patients and a family history of a clotting-factor disorder are the other common reasons.

Surgeons and proceduralists often request a PT/INR before an operation. Guidelines from the British Society for Haematology note that routine clotting screens in people with no bleeding history do not predict surgical bleeding well and are not recommended as a blanket rule, but many hospitals and outpatient procedure centers still require the result, and it is a reasonable pre-op check for anyone with liver disease, a bleeding history or a blood-thinning medication.

PT with INR can be ordered by your doctor or anticoagulation clinic, or online through TestWell for a draw at a Quest or Labcorp patient service center, with a licensed physician reviewing the order and results in your portal within a few business days. It is available on its own, paired with PTT as a full clotting screen, or inside a blood clotting panel; the paired version is the one to choose for unexplained bleeding, because the pattern across both tests is what points to a cause.

No fasting is needed. The sample is drawn into a light-blue citrate tube that must be filled to its line and mixed properly, and it has to be tested within about a day, so a walk-in lab is a better setting than a mailed kit. Tell the ordering physician about every medication and supplement: warfarin, direct oral anticoagulants (apixaban, rivaroxaban, dabigatran), heparin, antibiotics, and supplements such as vitamin K, fish oil, high-dose vitamin E, cranberry, ginkgo and St John's wort, all of which can move the result.

If you take warfarin, keep your routine the same before the test: take the dose at your usual time, do not change how much leafy-green vegetable you eat that week, and avoid a heavy alcohol intake the night before. The point of the INR is to see the effect of the dose you are actually taking, so the sample should reflect an ordinary day.

A typical adult prothrombin time is about 11 to 13.5 seconds; your report will show the range for the reagent your lab uses, which may run a second or so either side. For someone not taking an anticoagulant, a normal INR is roughly 0.8 to 1.1. An INR above about 1.2 to 1.3 in a person on no blood thinner is the point at which clinicians start looking for a reason, and readings above 1.5 in liver disease or before a procedure carry weight in decisions.

For people on warfarin the goal is deliberately abnormal. The CHEST antithrombotic guidelines set an INR target of 2.0 to 3.0 for most indications, including atrial fibrillation, deep vein thrombosis and pulmonary embolism. The 2020 ACC/AHA valve guideline sets 2.5 to 3.5 for mechanical mitral valves and for mechanical aortic valves with additional risk factors, and 2.0 to 3.0 for an uncomplicated mechanical aortic valve. Your prescriber will tell you which range is yours; a reading inside it is a normal result for you, even though the lab flags it as high.

Two cautions on reading the number. PT and INR are not a reliable measure of the direct oral anticoagulants; rivaroxaban and edoxaban can prolong PT somewhat and apixaban barely moves it, so a normal INR does not mean one of these drugs has worn off. And a slightly long PT with a normal PTT in someone who is otherwise well is often an early sign of low vitamin K or mild liver strain rather than a bleeding disorder; the section on what happens after an abnormal result covers the follow-up.

The most common reason for a high INR is the intended one: warfarin. When the INR climbs above the target range the usual causes are a new medication that interacts (many antibiotics, amiodarone, some antifungals, and high doses of acetaminophen are frequent culprits), an illness with poor eating, a drop in vitamin K intake, alcohol, or a dosing mix-up. An INR that is a little above range without bleeding is common and managed by the anticoagulation clinic; a very high INR, or any INR with bleeding, needs a same-day call.

In someone not on warfarin, the causes in rough order of frequency are vitamin K deficiency (poor diet, prolonged antibiotics that clear the gut bacteria that make vitamin K, fat malabsorption from celiac disease, bile-duct obstruction or pancreatic insufficiency), liver disease (the liver simply makes fewer factors, so PT rises as function falls and is a sensitive short-term marker of how sick a liver is), and disseminated intravascular coagulation, in which widespread clotting in a critically ill patient consumes the factors. Direct oral anticoagulants, particularly rivaroxaban, can also prolong PT.

Rarer causes include an inherited or acquired deficiency of a single factor. Factor VII deficiency is the classic finding when PT is long but PTT is normal; deficiencies of X, V, II or fibrinogen lengthen both tests. A sample problem is always on the list too: an under-filled citrate tube, a very high hematocrit, or a sample that sat too long can all produce a falsely long PT, which is why an unexpected result is repeated before anything is concluded.

A PT below the reference range, or an INR under 0.8, rarely means anything on its own. It can follow a recent vitamin K-rich diet or supplement, reflect a naturally high factor VII level, or appear early in disseminated intravascular coagulation before the factors are used up. In someone on warfarin, a low INR is the meaningful version: the dose is not protecting against clots, and the prescriber usually adjusts it and rechecks within days.

A short PT does not by itself indicate a clotting tendency, and the inherited conditions that do raise clot risk (factor V Leiden, prothrombin gene mutation, antiphospholipid antibodies) are looked for with their own tests, not with PT. If a low result comes with a personal or family history of unexplained blood clots, that separate thrombophilia work-up is the right next step.

PT and PTT test different halves of the clotting cascade and are most useful side by side. PT covers the extrinsic and common pathways (factors VII, X, V, II and fibrinogen) and tracks warfarin, vitamin K and the liver. PTT covers the intrinsic pathway (factors VIII, IX, XI and XII) plus the same common pathway, and tracks heparin, hemophilia A and B, von Willebrand disease and the lupus anticoagulant.

The pattern narrows the search quickly. A long PT with a normal PTT points to factor VII: early warfarin effect, early vitamin K deficiency, early liver disease or a factor VII deficiency. A normal PT with a long PTT points to heparin, hemophilia, von Willebrand disease or a lupus anticoagulant, the last of which paradoxically raises clot risk. Both prolonged points to the shared pathway or to a global problem: significant liver disease, severe vitamin K deficiency, a warfarin overdose, disseminated intravascular coagulation, or a deficiency of factor X, V, II or fibrinogen.

On warfarin, an out-of-range INR goes to the anticoagulation clinic or prescriber the same day. Small excursions are handled by adjusting the dose and rechecking within about a week; a markedly high INR may be managed by holding doses or with vitamin K, and any bleeding, black or bloody stools, blood in the urine, a severe headache or a fall on a high INR is an emergency. The CHEST guidelines describe the thresholds clinicians use; the decisions are theirs, not something to work out from the number alone.

Off warfarin, the first step for an unexpectedly high result is a repeat on a properly filled sample together with a PTT, a liver panel and a complete blood count with platelets. A long PT that corrects when the sample is mixed with normal plasma points to a factor deficiency and prompts factor assays or a trial of vitamin K under a clinician's direction; one that does not correct suggests an inhibitor such as a lupus anticoagulant. Persistent unexplained prolongation, or any prolongation with bleeding, is a hematology referral. Mild elevations that resolve after vitamin K or after an antibiotic course ends need nothing further beyond a recheck.